Carregant...
Targeting Glucocorticoid Metabolism in Prostate Cancer
In the treatment of metastatic prostate cancer, resistance to hormonal therapy is a major obstacle. With antiandrogen therapies that suppress androgen signaling through the androgen receptor (AR), the primary driver of prostate cancer, some malignancies are able take advantage of the closely related...
Guardat en:
| Publicat a: | Endocrinology |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8312637/ https://ncbi.nlm.nih.gov/pubmed/34180973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/endocr/bqab132 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|